Healthcare & Pharmaceuticals

International drugs companies should seek to reduce prices for medicines sold to the poorest countries and avoid filing for patent protection there, a report prepared for the World Health Organisation (WHO) said on Monday.
Sun Pharma, India's biggest drug manufacturer, has been sent a warning letter about violations of manufacturing regulations at its Halol plant in Gujarat by the United States Food and Drug Administration (FDA). Indian companies supply as much as 40 percent of the drugs sold in the U.S.
Novartis, the Swiss pharmaceutical company, will appear before the Indian Supreme Court Wednesday to appeal against a patent rejection for a popular cancer drug. A decision in favor of the company could have a devastating impact on cheap supplies of many kinds of generic drugs for poor patients.
Appalled by the announcement of a collaboration between the National Cancer Institute (NCI) and General Motors (GM) on a breast cancer drug trial, activists today criticized the project as a profit-seeking move for the automobile corporation and the pharmaceutical companies involved.
From golden rice to anti-viral tomatoes, is the biotech industry's third generation good medicine or good marketing? And, activists ask, what are the environmental consequences?
The Supreme Court ruled, in one of its most closely watched property rights cases in years, that fostering economic development is an appropriate use of the government's power of eminent domain.
Eli Lilly, an Indianapolis based company, that has sold insulin products to diabetes patients since 1921, has quietly raised some U.S. prices 700 percent in the last 20 years by marketing so-called improved versions to consumers. Novo Nordisk, a Danish company, has also profited handsomely from this practice.
GlaxoSmithKline (GSK) has been accused of bribing doctors in China in order to boost sales. Chinese government officials say they have uncovered evidence of a bribery scheme involving 700 travel agencies who were used to funnel as much as three billion yuan ($480 million) in payments.
Scalpers are doing a booming business in key medical drugs by taking advantage of U.S. patients and hospitals when they are desperate for supplies from the poorly regulated $46 billion global contract-manufacturing industry.
As you already know, the governments of the western hemisphere and their corporate bosses are signing our names to the Free Trade Agreement of the Americas as we speak. This secret treaty's being made to destroy activist victories, privatize public services, and gut public safeguards; to roll back everything that 500 years of resistance has won.